Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed No phase listed Observational

The EMPOWER Study: Endometriosis Diagnosis Using MicroRNA

ClinicalTrials.gov ID: NCT04598698

Public ClinicalTrials.gov record NCT04598698. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 8:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Endometriosis Diagnosis Using MicroRNA: Prospective Study in Women to Allow Early Disease Recognition

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Endometriosis is a complex, heterogeneous disease that may present inconsistently across women. Using disease-specific biomarkers and advanced biostatistics, DotLab is developing a biomarker test to confirm the presence of endometriosis.This is a multi-center, prospective, observational, minimal risk study in women undergoing laparoscopy, laparotomy or other pelvic surgical procedure for endometriosis, infertility or another benign gynecological indication. Participants will undergo 2 study visits for collection of blood and saliva and completion of study questionnaires.

Study identification

NCT ID
NCT04598698
Recruitment status
Not listed
Study type
Observational
Phase
Not listed
Lead sponsor
Dot Laboratories, Inc.
Industry
Enrollment
750 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 49 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 1, 2020
Primary completion
May 2, 2023
Completion
Nov 30, 2024
Last update posted
Aug 29, 2024

2020 – 2024

United States locations

U.S. sites
23
U.S. states
16
U.S. cities
21
Facility City State ZIP Site status
Stanford University Hospital Palo Alto California 94031
Center for Special Minimally Invasive & Robotic Surgery Woodside California 94061
Yale University New Haven Connecticut 06510
Christiana Care Newark Delaware 19713
RAD Fertility Newark Delaware 19713
MedStar Washington Hospital Center Washington D.C. District of Columbia 20010
University of South Florida Tampa Florida 33606
Academia of Women's Health and Endoscopic Surgery Atlanta Georgia 30328
Northwestern Medicine Chicago Illinois 60611
NorthShore University HealthSystem Evanston Illinois 60201
The Advanced Gynecologic Surgery Institute Park Ridge Illinois 60068
University of Louisville Hospital Louisville Kentucky 40202
Johns Hopkins University Baltimore Maryland 21205
Rutgers Robert Wood Johnson University Hospital New Brunswick New Jersey 08901
NewYork-Presbyterian / Columbia University Medical Center New York New York 10019
University Hospitals Cleveland Ohio 44106
Cleveland Clinic Cleveland Ohio 44195
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Penn State Health Hershey Pennsylvania 17033
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
UT Austin Austin Texas 78712
Seattle Reproductive Medicine Seattle Washington 98109

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Endometriosis trials

Other public records listing Endometriosis. Sorted by last update posted; newest first. Not a recommendation.

All Endometriosis trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04598698, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 29, 2024 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04598698 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →